Oliver O. Aalami, MD

Clinical Professor, Surgery - Vascular Surgery

Clinical Focus

Vascular Surgery
Endovascular Surgery
Digital Health
Health Information Technology
Precision Medicine

Academic Appointments

Clinical Professor, Surgery - Vascular Surgery
Member, Cardiovascular Institute
Member, Wu Tsai Human Performance Alliance

Administrative Appointments

Director, Biodesign for Digital Health, Stanford Byers Center for Biodesign (2018 - Present)
Medical Director, Wound Clinic, VAPAHCS (2014 - Present)
Medical Director, Vascular Laboratory, VAPAHCS (2012 - Present)

Professional Education

Medical Education: Boston University School of Medicine (1998) MA
Residency: UCSF East Bay Surgery Residency (2005) CA
Internship: UCSF East Bay Surgery Residency (1999) CA
Board Certification: American Board of Surgery, Vascular Surgery (2010)
Board Certification: American Board of Surgery, General Surgery (2007)
Fellowship: Northwestern University Medical Center (2007) IL

Contact

Academic aalami@stanford.edu

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Vascular Center 300 Pasteur Dr Rm H3640 MC 5308 Stanford CA 94305 Tel: (650) 725-5227 Fax: (650) 498-6044

Additional Clinical Info

Current Research and Scholarly Interests

We launched a national precision medicine PAD trial called, VascTrac (http://vasctrac.stanford.edu/). This trial is mobile phone based and leverages Apple's ResearchKit Platform to monitor a patient's activity both pre- and post-intervention. We are validating mobile phone surveillance for PAD patients and are currently enrolling.

Clinical Trials

Distributed Registry Not Recruiting
More
The purpose of this study is to test if a patient can be directly connected to a quality assurance (QA) database, traditionally known as a registry. Patient-reported outcomes (PRO) data will be entered into the database directly from a patient's mobile phone from their index procedure for 12 months. The investigators hope this study to be a "proof of concept" for such a distributed registry and evaluate 1) consistency of data acquisition, 2) engagement of patients, 3) overall value of patient-reported outcomes to enhance long term follow up.

Stanford is currently not accepting patients for this trial. For more information, please contact Doran S Triggs, BS, 650-852-3459.

Lead Sponsor
- Stanford University
Stanford Investigators
- Oliver O. Aalami, MD
View full details
VascTrac Peripheral Arterial Disease (PAD) Study Not Recruiting
More
VascTrac is a mobile medical application that tracks users' physical activity levels in order to predict endovascular failure of patients with Peripheral Artery Disease.

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .
Lead Sponsor
Stanford Investigators
- Oliver O. Aalami, MD
View full details
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial Not Recruiting
More
Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization and intensive medical management versus medical management alone in patients with asymptomatic high-grade carotid stenosis. One trial will randomize patients in a 1:1 ratio to endarterectomy versus no endarterectomy and another will randomize patients in a 1:1 ratio to carotid stenting with embolic protection versus no stenting. Medical management will be uniform for all randomized treatment groups and will be centrally directed.

Stanford is currently not accepting patients for this trial. For more information, please contact Brittanie D Baughman, 650-493-5000 Ext. 68632.
Lead Sponsor
Stanford Investigators
View full details
Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms Not Recruiting
More
The purpose of this study is to determine if telmisartan is effective in slowing the progression of abdominal aortic aneurysms and reducing circulating concentrations of Abdominal Aortic Aneurysms (AAA) biomarkers.

Stanford is currently not accepting patients for this trial. For more information, please contact Ronald Dalman, 6507232169.
Lead Sponsor
Stanford Investigators
- Oliver O. Aalami, MD
- Ronald L. Dalman MD
View full details

All Publications

Profiles With Related Publications

close
Helen M. Blau

Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences
Research Interests
Prof. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.

302 Total Publications
close
Sangkyun Cho

Instructor, Cardiovascular Institute

23 Total Publications
close
Christopher H. Contag

Professor of Pediatrics (Neonatology), Emeritus
Research Interests
We develop and use the tools of molecular imaging to understand oncogenesis, reveal patterns of cell migration in immunosurveillance, monitor gene expression, visualize stem cell biology, and assess the distribution of pathogens in living animal models of human biology and disease. Biology doesn't occur in "a vacuum" or on coated plates--it occurs in the living body and that's were we look for biological patterns and responses to insult.

355 Total Publications
close
Gerald Crabtree

David Korn, MD, Professor of Pathology and Professor of Developmental Biology
Research Interests
Chromatin regulation and its roles in human cancer and the development of the nervous system. Engineering new methods for studying and controlling chromatin and epigenetic regulation in living cells.

265 Total Publications
close
Edgar Engleman

Professor of Pathology and of Medicine (Immunology and Rheumatology)
Research Interests
Dendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.

289 Total Publications
close
Jill Helms

Professor of Surgery (Plastic & Reconstructive Surgery)
Research Interests
Dr. Helms' research interests center around regenerative medicine and craniofacial development.

213 Total Publications
close
Paul A. Khavari, MD, PhD

Carl J. Herzog Professor of Dermatology in the School of Medicine
Clinical Focus
Cancer > Cutaneous (Dermatologic) Oncology, Dermatology, General Dermatology
Research Interests
We work in epithelial tissue as a model system to study stem cell biology, cancer and new molecular therapeutics. Epithelia cover external and internal body surfaces and undergo constant self-renewal while responding to diverse environmental stimuli. Epithelial homeostasis precisely balances stem cell-sustained proliferation and differentiation-associated cell death, a balance which is lost in many human diseases, including cancer, 90% of which arise in epithelial tissues.

224 Total Publications
close
Dr. Michael T. Longaker

Deane P. and Louise Mitchell Professor in the School of Medicine and Professor, by courtesy, of Materials Science and Engineering
Clinical Focus
Plastic Surgery, Plastic Surgery, Pediatric
Research Interests
We have six main areas of current interest: 1) Cranial Suture Developmental Biology, 2) Distraction Osteogenesis, 3) Fibroblast heterogeneity and fibrosis repair, 4) Scarless Fetal Wound Healing, 5) Skeletal Stem Cells, 6) Novel Gene and Stem Cell Therapeutic Approaches.

1141 Total Publications
close
H. Peter Lorenz, MD

Professor of Surgery (Plastic and Reconstructive Surgery)
Clinical Focus
Plastic Surgery, Pediatric, Plastic Surgery, Cleft lip and palate surgery, Facial surgery, Plastic and Reconstructive Surgery, facial fracture surgery, Body contouring surgery, abdominal wall surgery, ventral hernia surgery, incisional hernia surgery
Research Interests
We have three areas of current investigation:
1) Scarless skin wound healing biology
2) Dot stem cell tissue regeneration biology
3) Novel stem cell therapy for tissue engineering

144 Total Publications
close
Mark Mercola

Professor of Medicine (Cardiovascular) and, by courtesy, of Chemical and Systems Biology

235 Total Publications
close
Randall Morris

Professor (Research) of Cardiothoracic Surgery, Emeritus
Research Interests
Discovery, preclinical and clinical development of novel immunosuppressive molecules for prevention or treatment of immune or inflammatory or ischemic injury to cell and organ transplants and for suppression of autoimmune diseases and acute organ injuries including small molecule, monoclonal and biologic classes of therapeutics.

208 Total Publications
close
Hiromitsu (Hiro) Nakauchi

Professor of Genetics (Stem Cell)

571 Total Publications